Glean was founded in 2019 and spent its early years building enterprise search and knowledge-management software powered by large language models. In a private market marketplace, the product connects to a company's internal tools — Slack, Google Drive, Salesforce, Confluence, and dozens of others — and surfaces relevant information across all of them through a single interface.

Through late 2024 and into 2025, the company reported strong ARR growth and expanded its customer base among large enterprises. Its most recent primary round, a Series E closed in late 2024, was led by Kleiner Perkins and valued the company at $4.6 billion. If you're still building foundational context on how pre-IPO investing and secondary markets price high-growth enterprise AI companies, review the complete guide to pre-IPO investing before interpreting these valuation signals. By early 2026, secondary marks on platforms tracking reported trades were consistently above that figure, reflecting the general enthusiasm for enterprise AI infrastructure. The question buyers on secondary markets should be asking is not whether Glean is a good business. The question is: what does the secondary transaction actually give me, what is the realistic price, and what are the structural risks I need to price in?

The question buyers on secondary markets should be asking is not whether Glean is a good business. The question is: what does the secondary transaction actually give me, what is the realistic price, and what are the structural risks I need to price in?

What you are buying in a secondary transaction

In almost every secondary transaction for a private company like Glean, the buyer does not become a direct shareholder on the company's cap table. Instead, you are purchasing a membership interest in a special purpose vehicle — an SPV — that holds the shares, or you are entering a forward contract that settles in shares or cash at a future liquidity event.

The SPV structure is the most common. A seller transfers their shares (or the economic rights to them) into the SPV; you buy an interest in that SPV. Your rights flow through the SPV's operating agreement, not directly through the company's investor rights agreement. You typically do not get information rights, pro-rata rights, or board observation rights unless those were explicitly retained in the SPV formation documents.

This matters for Glean specifically because the company, like most enterprise software companies at this stage, has not yet signaled a public offering timeline. Secondary buyers should understand that they may be holding an illiquid SPV interest for several years. The SPV itself will carry management fees and, in many cases, carried interest — typically 10–20% of profits above a hurdle. Those fees come directly out of your net return.

SPV (Special Purpose Vehicle)
A limited liability company or partnership formed solely to hold shares in one company. Secondary buyers purchase membership interests in the SPV rather than direct shares.
Carried interest (carry)
A share of profits — typically 10–20% — paid to the SPV manager above an agreed return threshold. Carry reduces the buyer's net gain on exit.
Forward contract
An agreement to buy shares at a future date and pre-agreed price, typically contingent on a liquidity event. Counterparty risk is higher than in an SPV because no shares are held in trust today.
ROFR (Right of First Refusal)
A contractual right held by the company or existing investors to purchase shares before an outside buyer can complete the transaction. Exercise of ROFR collapses the secondary deal.

The ROFR question for Glean

Glean's investor rights agreement, like those of most VC-backed companies, almost certainly contains a right of first refusal in favor of the company and potentially its major investors. Under a typical ROFR clause, when a shareholder proposes to transfer shares to a third party, the company (and sometimes existing investors in sequence) can step in and buy those shares on the same terms as the proposed transaction.

In practice, ROFR exercise rates on secondary trades vary widely by company and by market environment. When a company is growing and management wants to control its cap table, ROFR exercise is more likely. When a company is indifferent or when the transfer is structured carefully, ROFR is often waived. But buyers should treat ROFR as a live risk, not a technicality.

If Glean's company or investors exercise ROFR after you have already committed to a transaction, your deal falls through. You are returned any funds held in escrow, but you have lost the time and opportunity cost of the position. At Limen Markets, we clear ROFR in parallel with execution rather than sequentially — that process compresses the timeline, but it does not eliminate ROFR risk.

ROFR is a cap table management tool, not just a legal formality. In a rising-price environment, existing investors have an economic incentive to exercise it. Buyers should ask explicitly how ROFR is handled before committing.

Reading the implied valuation

Secondary prices for Glean in early 2026 have been quoted at premiums to the $4.6 billion Series E valuation. That premium reflects genuine demand for enterprise AI exposure among accredited investors and family offices. But buyers should pressure-test the implied multiple before paying it.

Glean does not publish revenue figures. Market participants typically triangulate ARR from hiring patterns, customer announcements, and data from third-party revenue intelligence providers. As of early 2026, credible estimates placed Glean's ARR in the $150–200 million range. At a secondary valuation of $5–6 billion, that implies a revenue multiple of 25–40x.

That multiple is not irrational in the context of enterprise AI infrastructure — the public comps for high-growth SaaS with strong NRR and low churn do support elevated multiples. But it assumes continued growth at current rates, which requires large enterprise deals to continue closing and the competitive environment to remain manageable. Microsoft, Google, and ServiceNow are all building or acquiring similar functionality.

Secondary buyers are essentially pricing both the growth trajectory and the liquidity timeline. If Glean takes three to five more years to reach a liquidity event, the implied IRR on a 35x revenue multiple today requires substantial further multiple expansion or a significant step-up in ARR — or both.

Supply and settlement dynamics

Secondary supply for Glean is driven primarily by early employees and former employees who hold vested common stock or exercised options. Angels and seed-stage investors who received preferred stock early may also be sellers, though preferred holders have less incentive to transact at discounts to their liquidation preferences.

The nature of the supply matters for settlement. Common stock sold through an SPV typically requires the seller to assign their economic rights into the SPV entity, which then requests a ROFR waiver from the company. This process can take anywhere from a few days to several weeks depending on the company's responsiveness and legal counsel. Forward contracts settle faster in terms of paperwork but introduce counterparty risk that persists until delivery.

Buyers should also confirm what class of shares underlies the SPV interest they are purchasing. Common stock ranks behind all series of preferred stock in a liquidation. If Glean's exit is an acquisition at a modest premium to the last primary round valuation, preferred shareholders may be made whole while common shareholders recover significantly less — or nothing, depending on liquidation preferences and participating provisions.

Questions to ask before placing an indication on Glean

  • Is the underlying interest common stock, Series A, or a later preferred series — and what are the liquidation preference and participation terms?
  • Is the vehicle an SPV with held shares, or a forward contract? If SPV, what are the management fee and carry terms?
  • Has the platform confirmed seller-side supply before accepting your indication, or are they brokering an unconfirmed match?
  • What is the ROFR process, and how long has it historically taken for comparable transactions at this company?
  • What is your realistic holding period assumption, and what IRR does the current ask price imply at a range of exit valuations?
  • If the company raises a new primary round at a higher or lower valuation before you exit, how does the SPV operating agreement address dilution or mark-down?
The most important question is often the simplest: what class of shares am I buying, and what happens to that class in an acquisition at 1.5x the last primary round?

Next step

If you are considering Glean pre-IPO shares or any of the other 27 issuers on our platform, the marketplace shows confirmed supply refreshed hourly with $25k minimums per name. If you want to understand the structural differences between taking an SPV interest versus a direct transfer before placing an indication, the SPV versus direct secondary guide under ROFR covers that comparison in detail.